[Mexican consensus on the diagnosis and treatment of atopic dermatitis in adolescents and adults]
- PMID: 30278478
- DOI: 10.29262/ram.v65i6.526
[Mexican consensus on the diagnosis and treatment of atopic dermatitis in adolescents and adults]
Abstract
Background: The diagnostic approaches and therapeutic strategies of atopic dermatitis (AD) are generally inconsistent among physicians and health institutions.
Objective: To develop a consensus statement among experts to reduce the variations in practice regarding the diagnosis and treatment of patients ≥ 12 years with AD to improve their care.
Methods: Systematic literature search in PubMed and GREAT. With methodological support and using the Delphi method, a formal consensus was developed among 16 experts in Dermatology and Allergology, based on the current evidence and its applicability in the Mexican context. Apart from intense electronic communication, several issues of disagreement were discussed in two face-to-face meetings.
Results: The clinical experts reached consensus on 46 statements related to the definition, classification, diagnostic strategies and treatment of AD. For the diagnosis we suggest the Williams criteria and for severity scoring the SCORAD (by the doctor) and POEM (by the patient). In addition to general care and treatment education (workshops), we suggest four steps for treatment, depending on severity: 1. Topical treatment with anti-inflammatory agents (and systemic: antihistamines/antileukotrienes -low level evidence-) 2. Phototherapy, 3. Cyclosporin A and 4. Dupilumab, with the possibility of managing this biological earlier on if a fast effect is needed. In extrinsic AD we suggest evaluating the addition of allergen immunotherapy or an elimination diet, if there is an IgE-mediated respiratory or food allergy, respectively.
Conclusion: The panel of experts reached consensus on relevant aspects of AD with a focus on the transcultural adaptation of recent evidence.
Antecedentes: Los abordajes diagnósticos y las estrategias terapéuticas de la dermatitis atópica generalmente son inconsistentes entre los médicos y entre las instituciones de salud. Objetivo: Consensar las opiniones de expertos para reducir las variaciones en la práctica respecto al diagnóstico y tratamiento de pacientes ≥ 12 años con dermatitis atópica para mejorar su cuidado. Métodos: Búsqueda sistemática de la literatura en PubMed y GREAT. Con apoyo metodológico y utilizando el método Delphi se desarrolló un consenso formal entre 16 expertos en dermatología y alergología, basándose en la evidencia actual y su aplicabilidad en el contexto mexicano. A parte de una comunicación electrónica intensa, se discutieron los puntos en desacuerdo en dos reuniones presenciales. Resultados: Los expertos clínicos alcanzaron consenso en 46 declaraciones relacionadas con la definición, clasificación, estrategias de diagnóstico y tratamiento de la dermatitis atópica. Para el diagnóstico sugerimos se usan los criterios de Williams y el SCORAD (por parte del médico) y POEM (por parte del paciente) para definir la gravedad. Aunado a cuidados generales y educación terapéutica, sugerimos cuatro pasos para tratamiento, según gravedad: 1. Manejo tópico con antiinflamatorio (y sistémico: antihistamínico/antileucotrieno —evidencia reducida—) 2. Fototerapia, 3. Ciclosporina A y 4. Dupilumab, con la posibilidad de manejarlo antes si se necesita efecto rápido. En la dermatitis atópica extrínseca sugerimos agregar inmunoterapia con alérgenos o una dieta de eliminación si existe una alergia IgE-mediada, inhalatoria o alimentaria, respectivamente. Conclusión: El panel de expertos realizó consenso en aspectos relevantes de la dermatitis atópica con enfoque en la adaptación transcultural de evidencia reciente.
Keywords: Atopic dermatitis; Atopic dermatitis treatment; Biological treatment; Consensus; Cyclosporin A; Dupilumab; Omalizumab.
Similar articles
-
Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA).G Ital Dermatol Venereol. 2018 Apr;153(2):133-145. doi: 10.23736/S0392-0488.17.05892-8. Epub 2017 Dec 14. G Ital Dermatol Venereol. 2018. PMID: 29237258
-
Italian guidelines for therapy of atopic dermatitis-Adapted from consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis).Dermatol Ther. 2019 Nov;32(6):e13121. doi: 10.1111/dth.13121. Epub 2019 Nov 7. Dermatol Ther. 2019. PMID: 31625221
-
[Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].Pol Merkur Lekarski. 2004;17 Suppl 3:3-15. Pol Merkur Lekarski. 2004. PMID: 15688665 Review. Polish.
-
Updated consensus guidelines for management of moderate-to-severe atopic dermatitis in Singapore: Integrating biologics, Janus kinase inhibitors and conventional therapies.Ann Acad Med Singap. 2024 Nov 29;53(11):670-682. doi: 10.47102/annals-acadmedsg.2024158. Ann Acad Med Singap. 2024. PMID: 39636193 Review.
-
ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis.J Eur Acad Dermatol Venereol. 2010 Mar;24(3):317-28. doi: 10.1111/j.1468-3083.2009.03415.x. Epub 2009 Aug 31. J Eur Acad Dermatol Venereol. 2010. PMID: 19732254 Review.
Cited by
-
Healthcare Disparities in Atopic Dermatitis in Latin America: A Narrative Review.Dermatol Ther (Heidelb). 2023 Feb;13(2):399-416. doi: 10.1007/s13555-022-00875-y. Epub 2022 Dec 23. Dermatol Ther (Heidelb). 2023. PMID: 36562945 Free PMC article. Review.
-
Global Guidelines in Dermatology Mapping Project (GUIDEMAP), a systematic review of atopic dermatitis clinical practice guidelines: are they clear, unbiased, trustworthy and evidence based (CUTE)?Br J Dermatol. 2022 May;186(5):792-802. doi: 10.1111/bjd.20972. Br J Dermatol. 2022. PMID: 34984668 Free PMC article.
-
Symptom's resolution and growth outcome of children with cow's milk protein allergy consuming two hydrolyzed formulas: A retrospective study in Mexico.Front Allergy. 2023 Jan 30;4:1073430. doi: 10.3389/falgy.2023.1073430. eCollection 2023. Front Allergy. 2023. PMID: 36793546 Free PMC article.
-
Atopic Dermatitis in Latin America: A Roadmap to Address Data Collection, Knowledge Gaps, and Challenges.Dermatitis. 2022 Nov-Dec 01;33(6S):S83-S91. doi: 10.1097/DER.0000000000000904. Epub 2022 Jun 3. Dermatitis. 2022. PMID: 35648105 Free PMC article.
-
Guía de práctica clínica mexicana para el diagnóstico y tratamiento de las dislipidemias y enfermedad cardiovascular aterosclerótica.Arch Cardiol Mex. 2022;92(Supl):1-62. doi: 10.24875/ACM.M22000081. Arch Cardiol Mex. 2022. PMID: 35275904 Free PMC article. English.